Body Composition Analyzers Market Size to Surpass USD 618.71 Million by 2030, at a CAGR of 4.5%

According to the report published by Allied Market Research, the global body composition analyzers market generated $398.22 million in 2020, and is expected to hit $618.71 million by 2030, registering a CAGR of 4.5% from 2021 to 2030. The study analyzes the important strategies, drivers, competition, market dynamics, size, and important investment regions.

Key Takeaways:

The home users segment, however, would exhibit the fastest CAGR of 5.6% from 2021 to 2030.

The Asia-Pacific region would cite the fastest CAGR of 5.4% by the end of 2030.

The bio-impedance analyzer segment would also exhibit the fastest CAGR of 5.6% throughout the forecast period.

Request Sample Copy of the Report: 

https://www.alliedmarketresearch.com/request-sample/4294

Major Factors Driving the Growth of Cancer Pain Market:

• Increasing prevalence of cancer: Cancer is a major global health concern, with an estimated 19.3 million new cancer cases diagnosed worldwide in 2020. The prevalence of cancer is increasing due to a number of factors, including aging populations, unhealthy lifestyles, and exposure to environmental carcinogens.

• Rising demand for effective pain management: Cancer pain can be severe and debilitating, and it can significantly impact a patient’s quality of life. This is driving demand for effective pain management options, including both pharmacological and non-pharmacological therapies.

• Advancements in pain management therapies: There have been significant advancements in the development of new and improved pain management therapies for cancer patients. These therapies include new oral medications, transdermal patches, and intrathecal therapies.

• Growing awareness of the benefits of palliative care: Palliative care is specialized medical care that focuses on improving the quality of life of patients with serious illnesses, including cancer. Palliative care teams can provide comprehensive pain management plans that include pharmacological, non-pharmacological, and psychological therapies.

Cancer Pain Market Segmentation:

By drug type:

• Nonsteroidal anti-inflammatory drugs (NSAIDs): NSAIDs are a class of drugs that reduce pain and inflammation. Examples of NSAIDs include ibuprofen (Advil, Motrin), naproxen (Aleve), and celecoxib (Celebrex).
• Opioids: Opioids are a class of drugs that bind to opioid receptors in the brain and spinal cord to relieve pain. Examples of opioids include morphine, fentanyl, and oxycodone.
• Adjuvants: Adjuvants are drugs that are used in combination with other pain medications to enhance their effectiveness. Examples of adjuvants include tricyclic antidepressants (TCAs), gabapentin (Neurontin), and pregabalin (Lyrica).
• Other drugs: Other drugs that are used to treat cancer pain include corticosteroids, anticonvulsants, and local anesthetics.

By route of administration:

• Oral: Oral medications are taken by mouth. This is the most common route of administration for cancer pain medications.
• Parenteral: Parenteral medications are administered by injection. This includes intravenous (IV), intramuscular (IM), and subcutaneous (SC) injections.
• Transdermal: Transdermal medications are applied to the skin in the form of a patch. This allows the medication to be absorbed slowly into the bloodstream over time.
• Topical: Topical medications are applied directly to the affected area. This can provide relief from pain and inflammation in a localized area.

By application:

• Acute cancer pain: Acute cancer pain is pain that is sudden and severe. It is often caused by cancer treatment, such as surgery or chemotherapy.
• Chronic cancer pain: Chronic cancer pain is pain that is ongoing and persistent. It can be difficult to control and can have a significant impact on a patient’s quality of life.
• Neuropathic cancer pain: Neuropathic cancer pain is pain that is caused by damage to the nerves. It can be burning, shooting, or tingling in nature.

By end user:

• Adults: Adults are the most common users of cancer pain medications.
• Children: Children with cancer may also experience pain that requires medication.
• Healthcare providers: Healthcare providers, such as oncologists, palliative care specialists, and pain management specialists, play a critical role in prescribing and managing cancer pain medications.

By region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

Request for Customization: https://www.alliedmarketresearch.com/request-for-customization/4294

Regional Growth Dynamics:

The market across North America held the lion’s share in 2020, garnering more than two-fifths of the global market. The Asia-Pacific region would cite the fastest CAGR of 5.4% by the end of 2030. The other provinces studied in the report include Europe and LAMEA.

Competitive Landscape:

• Bodystat Ltd.
• COSMED Srl
• General Electric Company (GE Healthcare)
• Hologic, Inc.
• Inbody Co., Ltd.
• Omron Corporation
• RJL Systems, Inc.
• SELVAS AI Inc. (Jawon Medical Co., Ltd.)
• Seca GmbH & Co.Kg.
• Tanita Corporation

Key Questions Answered in the Intelligent Study

What is the market size and growth rate of the global and regional market by various segments?
What is the market size and growth rate of the market for selective countries?
Which region or sub-segment is expected to drive the market in the forecast period?
What Factors are estimated to drive and restrain the market growth?
What are the key technological and market trends shaping the market?
What are the key opportunities in the market?
What are the key companies operating in the market?
Which company accounted for the highest market share?

Why Choose Allied Market Research?

Industries’ Best Analysts
Exclusive Product Offerings
Customer Research Services
Dynamics Research Methodology
Comprehensive Reports
Latest Technological Advancements
Value Chain Analysis
Future Market Opportunities
Market Growth Dynamics
Quality Assurance
Post-sales Support
Continuous Report Update

Market Dynamics and Transformations

Economic Downturn Analysis: Impact of Recession in 2023
Pandemic’s Influence: Impact of Covid-19 Pandemic
Market Evolution: Recent Developments in the Market with Key Players Announcements.

Buy this Premium Research Report: 

https://www.alliedmarketresearch.com/purchase-enquiry/4294

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.

Contact
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285                                                          
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
Follow Us on: LinkedIn Twitter